The World Health Organization has said it is creating a panel to study the implications of gene editing after a Chinese scientist controversially claimed to have created the world's first genetically-edited babies.
"It cannot just be done without clear guidelines," the head of the United Nations health agency, Tedros Adhanom Ghebreyesus, told reporters in Geneva Monday.
"WHO is putting together experts and we are working with member states...to discuss the standards and guidelines that can cover the ethical and social safety issues," added Tedros, a former Ethiopian health minister.
Tedros made the comments after a medical trial, which was led by Chinese scientist He Jiankui, claimed to have successfully altered the DNA of twin girls, whose father is HIV-positive, to prevent them from contracting the virus.
His experiment has prompted widespread condemnation from the scientific community in China and abroad, as well as a harsh backlash from the Chinese government.
Tedros said WHO was in the process of setting up the panel. He did not however characterise the initiative as a direct response to the Chinese trial.
He also declined to speculate on whether WHO could envision a future where some form of gene editing could offer public health benefits.
The panel will start with "a clean sheet," Tedros said. "They can start by asking 'should we even consider this?" The group will include academics as well as WHO and government medical experts, he added.
"We have to be very, very careful...We should not go into gene editing without understanding the unintended consequences." Last week, the Chinese ministry of science and technology stressed its opposition to the gene-editing baby experiment, and demanded a halt to the "scientific activities of relevant personnel".
The Chinese scientist's claims were "shocking and unacceptable" and breached "the bottom line of morality and ethics that the academic community adheres to", vice minister Xu Nanping told state broadcaster CCTV, warning that it may have broken the law.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
